Clinical Trials Logo

Filter by:
NCT ID: NCT00901914 Completed - Clinical trials for Rhinitis, Allergic, Seasonal

Study of rBet v1 Tablets

Start date: October 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the efficacy and safety of three doses of r Bet v1 administered as sublingual tablets in birch pollen allergic subjects.

NCT ID: NCT00901589 Completed - Postmenopause Clinical Trials

Marine n-3 Polyunsaturated Fatty Acids in Pre- and Postmenopausal Women

Start date: August 2007
Phase: N/A
Study type: Interventional

The study is a randomised placebo controlled double-blinded clinical trial where a group of healthy pre- and postmenopausal women is randomised to the intake of fish oil capsules or placebo oil capsules for 12 weeks. Anthropometric measurements(weight, height,blood pressure) blood samples and adipose tissue biopsies will be taken in order to illustrate the effect of marine n-3 PUFAs (fish oil) on the concentration of circulating female hormones and to investigate what impact menopause might have on the ability to incorporate marine n-3 PUFAs into tissues.

NCT ID: NCT00900731 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)

INTENSITY
Start date: June 2009
Phase: Phase 3
Study type: Interventional

This study compared the lung effects of indacaterol to those of tiotropium in patients with moderate to severe chronic obstructive pulmonary disease (COPD) over a 12 week period.

NCT ID: NCT00897169 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Trial Investigating the Possible Difference in Development of Type 2 Diabetes Between Caucasian and Japanese Subjects

Start date: June 2009
Phase: Phase 1
Study type: Interventional

This trial is conducted in Europe and Japan. The aim of this clinical trial is to investigate the possible difference in the development of type 2 diabetes in a Japanese and a Caucasian population. Healthy subjects, subjects with impaired glucose tolerance, as well as subjects with type 2 diabetes will be included in the trial. The development of type 2 diabetes across the cohort will be investigated with regard to insulin sensitivity and B-cell capacity.

NCT ID: NCT00894868 Completed - Clinical trials for Congestive Heart Failure

Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure

Start date: May 2009
Phase: Phase 4
Study type: Interventional

This study will assess the effect of vildagliptin on left ventricular function in patients with type 2 diabetes and congestive heart failure (NYHA Class I-III). Effect on HbA1c and overall safety and tolerability will also be assessed.

NCT ID: NCT00893893 Completed - Healthy Clinical Trials

Very-low-density-lipoprotein Triglyceride (VLDL-TG) Uptake in Visceral Fat

Start date: May 2009
Phase: N/A
Study type: Observational

Purpose: To investigate the uptake of VLDL-TG in visceral fat in lean and overweight individuals

NCT ID: NCT00892502 Completed - Multiple Myeloma Clinical Trials

Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?

Bismuth-PBH
Start date: May 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether treatment with Bismuth can reduce the toxicity of chemotherapy and radiotherapy in patients with malignant diseases of the blood.

NCT ID: NCT00891553 Completed - Osteoporosis Clinical Trials

CR9112792, a Follow-up of Study CR9108963

Start date: March 2009
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether bone mineral density has increased in a subgroup of postmenopausal osteoporotic women from study CR9108963, between 6 and 12 months following cessation of ronacaleret therapy.

NCT ID: NCT00891540 Completed - Pain, Postoperative Clinical Trials

Local Infiltration Analgesia With Ropivacaine Versus Placebo in Caesarean Section

Start date: July 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare systematic local infiltration with Ropivacaine 0.5 % versus Ropivacaine 0.2 % versus Placebo in patients undergoing elective caesarean section. The hypothesis is that systemic local infiltration will reduce pain and postoperative opioid consumption.

NCT ID: NCT00891345 Completed - Clinical trials for Hormone-refractory Prostate Cancer

Safety Study of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy

ALECSAT
Start date: April 2009
Phase: Phase 1
Study type: Interventional

This study is a phase I study of a new cell based prostate cancer therapy (ALECSAT). In this therapy specific cells from the patient's own immune system are isolated, activated and re-administered to the patient to boost a specific immune response against the cancer cells. The aim of the study is to show safety and tolerability for this type of therapy. It is the hypothesis that the cells administered during the therapy will attack the tumour cells and in this way stop or slow down the progression of disease.